BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28325710)

  • 1. No evidence of compensatory drug use risk behavior among heroin users after receiving take-home naloxone.
    Jones JD; Campbell A; Metz VE; Comer SD
    Addict Behav; 2017 Aug; 71():104-106. PubMed ID: 28325710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
    Williams AV; Marsden J; Strang J
    Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.
    Coffin PO; Sullivan SD
    Ann Intern Med; 2013 Jan; 158(1):1-9. PubMed ID: 23277895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.
    Seal KH; Downing M; Kral AH; Singleton-Banks S; Hammond JP; Lorvick J; Ciccarone D; Edlin BR
    J Urban Health; 2003 Jun; 80(2):291-301. PubMed ID: 12791805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
    Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
    J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.
    Langham S; Wright A; Kenworthy J; Grieve R; Dunlop WCN
    Value Health; 2018 Apr; 21(4):407-415. PubMed ID: 29680097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution of naloxone to heroin users.
    Darke S; Hall W
    Addiction; 1997 Sep; 92(9):1195-9. PubMed ID: 9374020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naloxone for administration by peers in cases of heroin overdose.
    Lenton SR; Dietze PM; Degenhardt L; Darke S; Butler TG
    Med J Aust; 2009 Oct; 191(8):469. PubMed ID: 19835548
    [No Abstract]   [Full Text] [Related]  

  • 9. 'I saved a life': a heroin addict's reflections on managing an overdose using 'take home naloxone'.
    George S; Boulay S; Begley D
    BMJ Case Rep; 2010 Sep; 2010():. PubMed ID: 22778195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose?
    Lenton SR; Hargreaves KM
    Med J Aust; 2000 Sep; 173(5):260-3. PubMed ID: 11130352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
    McDonald R; Campbell ND; Strang J
    Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot scheme shows that giving naloxone to families of drug users would save lives.
    Hurley R
    BMJ; 2011 Aug; 343():d5445. PubMed ID: 21868460
    [No Abstract]   [Full Text] [Related]  

  • 13. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.
    Maxwell S; Bigg D; Stanczykiewicz K; Carlberg-Racich S
    J Addict Dis; 2006; 25(3):89-96. PubMed ID: 16956873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription naloxone: a novel approach to heroin overdose prevention.
    Sporer KA; Kral AH
    Ann Emerg Med; 2007 Feb; 49(2):172-7. PubMed ID: 17141138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation.
    Williams AV; Strang J; Marsden J
    Drug Alcohol Depend; 2013 Sep; 132(1-2):383-6. PubMed ID: 23453260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tangled-up and blue: releasing the regulatory chokehold on take-home naloxone.
    Winstanley EL
    Addiction; 2016 Apr; 111(4):583-4. PubMed ID: 26995167
    [No Abstract]   [Full Text] [Related]  

  • 17. Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.
    Strang J; Bird SM; Parmar MK
    J Urban Health; 2013 Oct; 90(5):983-96. PubMed ID: 23633090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths.
    Strang J
    Addiction; 2015 Jul; 110 Suppl 2():27-35. PubMed ID: 26042565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What heroin users tell us about overdose.
    Baca CT; Grant KJ
    J Addict Dis; 2007; 26(4):63-8. PubMed ID: 18032233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overdoses among friends: drug users are willing to administer naloxone to others.
    Lagu T; Anderson BJ; Stein M
    J Subst Abuse Treat; 2006 Mar; 30(2):129-33. PubMed ID: 16490676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.